Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat in recurrent glioblastoma
NCT01115036Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- Apr 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in glioblastoma (GBM), sponsored by Duke University. Planned start Apr 2010; status: withdrawn.
02
Drugs
panobinostat
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01115036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01115036.